International Conference on Nuclear Medicine & Radiation Therapy

OMICS International is overwhelmed to welcome all the interested participants to its International Conference on Nuclear Medicine & Radiation Therapy during July 14-15, 2016 at Cologne, Germany. The International conference will be organized around the theme "Fusion of Emerging Technologies: Nuclear Medicine & Radiation Therapy". Nuclear Medicine 2016 is an event that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas, communicate and discuss research findings on new advancements in Radiology and Imaging techniques. This event focuses on cutting edge practical radiological technology that is used in every day practice. This is a two day multidisciplinary Congress covering all aspects of diagnostic imaging and oncology, including clinical service delivery, management, informatics and research.

Nuclear Medicine & Radiation Therapy is an emerging field of medicine; it has immense contribution towards diagnostic and therapeutic of diseases. Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and determine the severity of or treat a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body. Radiation therapy or radiotherapy is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body.

OMICS International has an enhanced and highlighted features of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research across the globe through live streaming, B2B and Scientific Meetings. OMICS International's Medical Conferences provides an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster. OMICS International Organizes 300+ Scientific Conferences every year across USA, Europe & Asia. Besides 500 Peer reviewed, Open Access Journals, OMICS International has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care and technologies. These journals are enjoying the support of over 5 million readers; a team of 30,000 eminent scholars are providing editorial support.

The history of nuclear medicine over the past 50 years reflects the strong link between government investments in science and technology and advances in health care in the United States and worldwide. Nearly 20 million nuclear medicine procedures using radiopharmaceuticals and imaging instruments are carried out annually in the United States alone. In 2014 an estimated 11.7 million patients received nuclear medicine scans on over 14,000 SPECT or SPECT/CT scanners in the U.S. This represents an average annual decline of 9.6% in procedures per year since 2012 when 14.5 million patient studies were performed. The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%.

Advances in Cancer Detection and Imaging

Imaging has become essential in all aspects of cancer care, from disease detection and characterization, to treatment response assessment and post treatment surveillance. Recent progress in imaging technology has presented new opportunities for improving clinical care. Interventional oncology, employing minimally invasive, image-guided techniques, is assuming an increasingly large role in treating cancer and its complications.

This scientific session will focus on various imaging technique and it impact on disease diagnosis such as Fluorescence Imaging Techniques, Digital Mammography & Computer-Aided Detection System, Electrical Impedance Scanning, Nanotechnology based Detection and Tumor Microarrays.